title: Kinetics of anti-fibrillin-1 autoantibodies in MCTD and CREST syndrome.
abstract: Using a highly sensitive Radioimmunoassay (RIA), the kinetics of synthesis of anti-fibrillin (Fbn-1) autoantibodies were studied in 17 patients with mixed connective tissue disease (MCTD) and two with CREST syndrome calcinosis, Raynaud's oesophageal dismotility, sclerodectyly and teleangiectasis who were found to be positive for this autoimmune response. IgG autoantibodies specific for recombinant Fbn-1 (rFbn-1) (aa 369-425) were found in all patients excepting one with MCTD, multiple sclerosis, and dermatomyositis. IgM were found in fewer cases. Several kinetics patterns of anti-Fbn-1 autoantibodies were observed: a) long lasting persistence of IgG and IgM autoantibodies up to 14 years; b) fluctuation of antibodies during various periods up to 16 years; c) disappearance of antibody response after several years, and d) patients producing IgG but not IgM autoantibodies. No differences in the synthesis of autoantibodies were observed between MCTD patients with a stable disease, and those developing during the course features of systemic sclerosis (SSc), Sjogren's syndrome, or rheumatoid-like arthritis. In one patient displaying a lupus-like syndrome for 3 years, the appearance of anti-Fbn-1 autoantibodies coincided with the occurrence of MCTD and scleroderma. While the detection of anti-Fbn-1 autoantibodies may be clinically useful in differential diagnosis or eventual prognosis of patients with connective tissue diseases, their role in the pathogenesis of scleroderma syndromes requires further investigation.
authors.affiliation: Department of Rheumatology, Karolinska Hospital, Stockholm, Sweden.
authors.forename: I
authors.initials: I
authors.lastname: Lundberg
authors.forename: S
authors.initials: S
authors.lastname: Antohi
authors.forename: K
authors.initials: K
authors.lastname: Takeuki
authors.forename: F
authors.initials: F
authors.lastname: Arnett
authors.forename: G
authors.initials: G
authors.lastname: Steiner
authors.forename: T D
authors.initials: TD
authors.lastname: Brumeanu
authors.forename: L
authors.initials: L
authors.lastname: Klareskog
authors.forename: C
authors.initials: C
authors.lastname: Bona
mesh_terms: D001323:Autoantibodies / Q000097:blood* / Q000276:immunology; D001324:Autoantigens / Q000276:immunology*; D017675:CREST Syndrome / Q000097:blood / Q000276:immunology*; D000071838:Fibrillin-1; D000071837:Fibrillins; D006801:Humans; D007700:Kinetics; D008840:Microfilament Proteins / Q000276:immunology*; D008947:Mixed Connective Tissue Disease / Q000097:blood / Q000276:immunology*; D054392:Adipokines
chemical_list: D001323:Autoantibodies; D001324:Autoantigens; D000071838:Fibrillin-1; D000071837:Fibrillins; D008840:Microfilament Proteins; C000605722:FBN1 protein, human; D054392:Adipokines